Literature DB >> 30938220

Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?

Barbara Bonnesen1,2, Gertrud Baunbæk Egelund1,2, Andreas Vestergaard Jensen1,2, Stine Andersen1,2, Pelle Trier Petersen1,2, Gernot Rohde3,4, Pernille Ravn2,5.   

Abstract

BACKGROUND: It is still a matter of debate whether the outcome of community acquired pneumonia is more severe in patients with chronic obstructive pulmonary disease. We aimed to determine whether chronic obstructive pulmonary disease was associated with increased mortality and to identify risk-factors for mortality in patients with community acquired pneumonia and chronic obstructive pulmonary disease.
METHODS: Retrospective cohort study comparing patients with community acquired pneumonia and chronic obstructive pulmonary disease to patients without chronic obstructive pulmonary disease. We included 1309 patients with community acquired pneumonia admitted from 2011 until 2012 (243 patients with chronic obstructive pulmonary disease and 1066 without chronic obstructive pulmonary disease).
RESULTS: At admission patients with community acquired pneumonia and chronic obstructive pulmonary disease presented with more severe pneumonia as measured by CURB-65 score compared to patients without chronic obstructive pulmonary disease. Mortality on day 30 was generally high, and higher among patients with community acquired pneumonia and chronic obstructive pulmonary disease compared to those without chronic obstructive pulmonary disease (16.0% versus 11.3%, p = .04). In an adjusted analysis, however, chronic obstructive pulmonary disease was not independently associated with 30-d mortality (odds ratio 0.94, confidence interval 95% 0.59-1.50). Factors related to mortality in patients with community acquired pneumonia and chronic obstructive pulmonary disease were age, premorbid condition, severity of pneumonia as determined by CURB-65 score, and pleural effusion and multi-lobular infiltrate on chest X-ray.
CONCLUSIONS: Chronic obstructive pulmonary disease was not independently associated with 30-d mortality in patients with community acquired pneumonia.

Entities:  

Keywords:  CAP; COPD; Chronic obstructive pulmonary disease; community acquired pneumonia; mortality

Year:  2019        PMID: 30938220     DOI: 10.1080/23744235.2019.1565416

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  5 in total

1.  Clinical efficacy of glucocorticoid and terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Yan Li; Zhi Xu; Cuo Qing; Hong Zhang; Xia Wu; Jilu Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  High Mean Platelet Volume Associates with In-Hospital Mortality in Severe Pneumonia Patients.

Authors:  Jieru Chen; Yihao Li; Yingsi Zeng; Yu Tian; Yueqiang Wen; Zebin Wang
Journal:  Mediators Inflamm       Date:  2020-06-08       Impact factor: 4.711

3.  A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.

Authors:  Dong Huang; Dingxiu He; Linjing Gong; Rong Yao; Wen Wang; Lei Yang; Zhongwei Zhang; Qiao He; Zhenru Wu; Yujun Shi; Zongan Liang
Journal:  Respir Res       Date:  2022-09-18

4.  Influence of Pneumonia on the Survival of Patients with COPD.

Authors:  Zichen Ji; Julio Hernández Vázquez; José María Bellón Cano; Virginia Gallo González; Beatriz Recio Moreno; Alicia Cerezo Lajas; Luis Puente Maestu; Javier de Miguel Díez
Journal:  J Clin Med       Date:  2020-01-15       Impact factor: 4.241

5.  The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis.

Authors:  Kunihiro Matsushita; Ning Ding; Minghao Kou; Xiao Hu; Mengkun Chen; Yumin Gao; Yasuyuki Honda; Di Zhao; David Dowdy; Yejin Mok; Junichi Ishigami; Lawrence J Appel
Journal:  Glob Heart       Date:  2020-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.